Back

The impact of air pollution on major adverse cardiovascular events (EP-PARTICLES Study)

24 April 2026 (10:39 - 10:48)
Organised by: Logo
Congress Presentation Part of: Environmental, psychosocial, and lifestyle determinants of cardiovascular health Environmental and Occupational Aspects of Heart Disease EAPC Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Anna Kurasz

Medical University of Bialystok, Bialystok (Poland)

4 More presentations in this session

Presentation thumbnail
Concomitant psychiatric, somatic, and social vulnerabilities in patients at greatest risk of cardiovascular disease: a latent class analysis
Mr Z. Yang (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Occupational noise exposure and long-term cardiovascular mortality in the united states: a 20-year nationally representative cohort study
Doctor I. Hassan (Houston, US)
Abstract Slides Video
Presentation thumbnail
Assessing the health burden of climate change in Poland: temperature extremes, air pollution, acute hospital admissions, and mortality over the years 2011-2020
Assistant Professor L. Kuzma (Bialystok, PL)
Abstract Slides Video
Presentation thumbnail
Longitudinal depressive symptom trajectories and the risk of new-onset atrial fibrillation
Ms N. Ntlapo (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Environmental, psychosocial, and lifestyle determinants of cardiovascular health
Video

The Event

Event poster

ESC Preventive Cardiology 2026

24 April 2026 10:39 CET
You may be interested in
thumbnail
Congress Presentation
Assessing the impact of air pollution on major adverse cardiovascular events. Insights from the EP-PARTICLES Cohort Study in Eastern Poland
thumbnail
Congress Presentation
Air pollution as a trigger for ischemic stroke - retrospective analysis of over 80-million-person years of follow-up (EP-PARTICLES study)
thumbnail
Congress Presentation
Heart in the midst of smog: the impact of air pollution on atrial fibrillation triggering (EP-PARTICLES Study)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources